A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)

NCT01477853 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

166

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated early by the Sponsor for business reasons.

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin
DRUG: Atorvastatin
OTHER: Placebo to sitagliptin
OTHER: Placebo to atorvastatin
DRUG: Metformin (open-label)
DRUG: Glimepiride (open-label)
DRUG: Glimepiride (double-blind)
DRUG: Placebo to glimepiride

Sponsor

Merck Sharp & Dohme LLC